iShares Biotechnology ETF
ETFYour view on IBB
iShares Biotechnology ETF
ETFISharesSentiment
AUM (USD)
$9.47B
Expense Ratio
0.44%
Holdings
247
Sentiment
Overview for iShares Biotechnology ETF
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- February 5, 2001
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- February 5, 2001
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- February 5, 2001
- Domicile
- US
About this fund
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
IBB Stock Price
Key Facts
EquityExpense Ratio
0.44%
AUM
$9.47B
Fund Details
Expense Ratio
0.44%
Assets Under Management
$9.47B
NAV
$192.93 USD
Holdings
247
Average Volume
1.55M
Inception Date
February 5, 2001
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US4642875565
CUSIP
464287556
NAV Currency
USD
Expense Ratio
0.44%
Assets Under Management
$9.47B
NAV
$192.93 USD
Holdings
247
Average Volume
1.55M
Inception Date
February 5, 2001
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US4642875565
CUSIP
464287556
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.